CA2486423A1 - Procedes et compositions diriges contre la modulation de la chimiosensation - Google Patents

Procedes et compositions diriges contre la modulation de la chimiosensation Download PDF

Info

Publication number
CA2486423A1
CA2486423A1 CA002486423A CA2486423A CA2486423A1 CA 2486423 A1 CA2486423 A1 CA 2486423A1 CA 002486423 A CA002486423 A CA 002486423A CA 2486423 A CA2486423 A CA 2486423A CA 2486423 A1 CA2486423 A1 CA 2486423A1
Authority
CA
Canada
Prior art keywords
antibody
complex
sensation
antibodies
xaa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002486423A
Other languages
English (en)
Inventor
Shmuel Ben-Sasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
TVD TASTE VIRTUAL DIMENSIONS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TVD TASTE VIRTUAL DIMENSIONS Inc filed Critical TVD TASTE VIRTUAL DIMENSIONS Inc
Publication of CA2486423A1 publication Critical patent/CA2486423A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des procédés et des anticorps dirigés contre la modulation de la chimiosensation. Plus précisément, l'invention concerne des procédés et des anticorps dirigés contre la modulation de la sensation de goût et des procédés et des anticorps dirigés contre la sensation d'odorat.
CA002486423A 2002-05-20 2003-05-20 Procedes et compositions diriges contre la modulation de la chimiosensation Abandoned CA2486423A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38205902P 2002-05-20 2002-05-20
US60/382,059 2002-05-20
US45163903P 2003-03-04 2003-03-04
US60/451,639 2003-03-04
PCT/IL2003/000409 WO2003102030A1 (fr) 2002-05-20 2003-05-20 Procedes et compositions diriges contre la modulation de la chimiosensation

Publications (1)

Publication Number Publication Date
CA2486423A1 true CA2486423A1 (fr) 2003-12-11

Family

ID=29715290

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002486423A Abandoned CA2486423A1 (fr) 2002-05-20 2003-05-20 Procedes et compositions diriges contre la modulation de la chimiosensation

Country Status (4)

Country Link
EP (1) EP1507801A1 (fr)
AU (1) AU2003230176A1 (fr)
CA (1) CA2486423A1 (fr)
WO (1) WO2003102030A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364867B2 (en) 2000-04-17 2008-04-29 The Mount Sinai School Of Medicine Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20140147556A1 (en) * 2012-11-27 2014-05-29 Elwha Llc Edible or inhalable compositions having antibodies and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201006846A (en) * 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
WO2003004992A2 (fr) * 2001-07-03 2003-01-16 The Regents Of The University Of California Recepteurs de gout heterodimeriques de gout sucre et d'acide amine, chez les mammiferes

Also Published As

Publication number Publication date
EP1507801A1 (fr) 2005-02-23
WO2003102030A1 (fr) 2003-12-11
AU2003230176A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
US20210340262A1 (en) Dual receptor antagonistic antigen-binding proteins and uses thereof
ES2646168T3 (es) Anticuerpos monoclonales para el receptor del factor de crecimiento de fibroblastos 2
Kawamata et al. Molecular properties of apelin: tissue distribution and receptor binding
JP5855569B2 (ja) 破骨細胞特異的抗原の生物学的活性を特異的にブロックする抗体
Palm et al. Mapping of β‐adrenoceptor coupling domains to Gs‐protein by site‐specific synthetic peptides
CN108697795A (zh) Gfral受体疗法
CN110036024A (zh) 肌肉性能改善化合物
KR20200038311A (ko) 항-아펠린 항체 및 그의 용도
CN106687478A (zh) 新的抗人Tie‑2抗体
CN113840831A (zh) 医用ngf拮抗剂
AU2005254613A1 (en) FGFR binding peptides
JP4980901B2 (ja) 新規なモノクローナル甲状腺刺激または阻害抗体、その可変領域に相当するペプチド配列、ならびに診断用医薬、予防用医薬および治療用医薬におけるそれらの使用
KR20220119117A (ko) 종양 특이적 claudin 18.2 항체
KR101953299B1 (ko) EGFRvIII에 대한 항체 및 이의 이용
CA2486423A1 (fr) Procedes et compositions diriges contre la modulation de la chimiosensation
JP2011097869A (ja) 抗ヒトアデノシンＡ２ａ受容体モノクローナル抗体
TW202024134A (zh) 雙特異性蛋白
JP5750700B2 (ja) アゴニストの親和性を亢進する抗ヒトアデノシンＡ２ａ受容体モノクローナル抗体
AU2009266414A1 (en) Anti-PAMP therapeutic antibodies
CN114656567A (zh) 抗icos抗体及其应用
Davies et al. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor
KR20220054585A (ko) 고분자 항체 수용체 표적화를 위한 재료 및 방법
CN101341170A (zh) 抗白介素-22结合蛋白的抗体及其用途
US20230242632A1 (en) Antigen binding constructs targeting her2 and uses thereof
WO2022242757A1 (fr) Application d'anticorps anti-pd-1

Legal Events

Date Code Title Description
FZDE Discontinued